Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Autor: Besse, B. *, Mazières, J., Ribassin-Majed, L., Barlesi, F., Bennouna, J., Gervais, R., Moreau, L., Berard, H., Debieuvre, D., Molinier, O., Moro-Sibilot, D., Souquet, P.J., Jacquot, S., Petit, L., Lena, H., Pignon, J.P., Lacas, B., Morin, F., Milleron, B., Zalcman, G., Soria, J.C.
Zdroj: In Annals of Oncology May 2017 28(5):1078-1083
Databáze: ScienceDirect